Shanghai Junshi Biosciences Co Ltd (688180) — Working Capital to Net Assets Ratio
Shanghai Junshi Biosciences Co Ltd (688180) has a Working Capital to Net Assets ratio of 26.9% as of September 2025. Working capital of CN¥1.70 Billion (current assets of CN¥4.45 Billion minus current liabilities of CN¥2.75 Billion) is measured against net assets of CN¥6.30 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 688180 net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Shanghai Junshi Biosciences Co Ltd Working Capital to Net Assets (2014–2024)
This chart shows how Shanghai Junshi Biosciences Co Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 26.9%, reflecting working capital of CN¥1.70 Billion against net assets of CN¥6.30 Billion CNY. Check how tangible is Shanghai Junshi Biosciences Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Shanghai Junshi Biosciences Co Ltd (2014–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Shanghai Junshi Biosciences Co Ltd from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 688180 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 29.4% | CN¥1.75 Billion | CN¥5.95 Billion | CN¥4.28 Billion | CN¥2.53 Billion | ▼ -12.9 pp |
| 2023 | 42.3% | CN¥3.10 Billion | CN¥7.32 Billion | CN¥5.57 Billion | CN¥2.48 Billion | ▼ -13.2 pp |
| 2022 | 55.4% | CN¥5.43 Billion | CN¥9.79 Billion | CN¥7.20 Billion | CN¥1.77 Billion | ▲ +9.5 pp |
| 2021 | 46.0% | CN¥3.83 Billion | CN¥8.33 Billion | CN¥5.83 Billion | CN¥2.00 Billion | ▼ -9.3 pp |
| 2020 | 55.2% | CN¥3.23 Billion | CN¥5.84 Billion | CN¥4.70 Billion | CN¥1.47 Billion | ▲ +11.5 pp |
| 2019 | 43.7% | CN¥1.31 Billion | CN¥2.99 Billion | CN¥1.91 Billion | CN¥605.38 Million | ▼ -29.8 pp |
| 2018 | 73.4% | CN¥2.44 Billion | CN¥3.32 Billion | CN¥2.91 Billion | CN¥471.06 Million | ▲ +33.0 pp |
| 2017 | 40.4% | CN¥452.45 Million | CN¥1.12 Billion | CN¥511.01 Million | CN¥58.56 Million | ▼ -6.3 pp |
| 2016 | 46.7% | CN¥525.95 Million | CN¥1.13 Billion | CN¥544.91 Million | CN¥18.96 Million | ▼ -32.5 pp |
| 2015 | 79.2% | CN¥486.43 Million | CN¥614.22 Million | CN¥500.59 Million | CN¥14.16 Million | ▼ -2.2 pp |
| 2014 | 81.4% | CN¥260.45 Million | CN¥319.87 Million | CN¥273.52 Million | CN¥13.07 Million | — |